NBN Gene Mutation
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects (NCT04030559) | University of California, Davis | 2020-02-25 |
| Olaparib In Metastatic Breast Cancer (NCT03344965) | Beth Israel Deaconess Medical Center | 2018-04-01 |
| Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer (NCT03377556) | SWOG Cancer Research Network | 2017-03-03 |
Track NBN Gene Mutation automatically
Every clearance here is in the API, with alerts when new ones post.